
    
      Aim1: To evaluate the safety and tolerability of three different lactoferrin doses in preterm
      infants

        1. Lactoferrin related adverse events and serious adverse events

        2. Number of infants reaching full feeds while receiving lactoferrin (120 ml/kg/day)

        3. Episodes of not receiving enteral feedings for > 24 hours once feeding is initiated

      Aim 2: To evaluate lactoferrin absorption and excretion.

        1. Examine lactoferrin levels in saliva, urine, plasma and stool

        2. Examine lactoferrin levels in maternal and human donor milk.

      Aim 3: To evaluate the effect of lactoferrin on the intestinal microbiome structure.
    
  